My Child Was Vulnerable Long Before the Pandemic. But the Wait for a Vaccine Is Excruciating

Whenever my 9-year-old seizes, he’s coming out of sleep—as though his brain gets stuck in an elevator between the basement of REM and the lobby of consciousness. Around 5 a.m., always on a day I couldn’t predict, his 50-pound frame starts to tap and jerk, keeping an awful rhythm, and, for too many seconds, he cannot say his name. Seizures are the latest in a litany of medical and developmental challenges that have puzzled his doctors for the last seven years, beginning with the morning his blood sugar dropped to 27 mg/dL. A normal range is around 70-100 mg/dL. We have medication and genetic test results, glucometers and nutrition plans, but we have no guarantees. My husband and I take turns easing liquid medicine into his mouth twice a day, pricking his finger when his energy lags, and blending a protein smoothie for him at night. We follow the rules, try to make a contract with our boy’s beautiful brown body. But each time he seizes, we are left without recourse. We hold him and push record on a phone, as though gathering evidence could ever be enough. [time-brightcove not-tgx=”true”] I thought we’d be in a different place by now. It’s a phrase I don’t dare say aloud following his seizures or doctors’ appointments. It would strip me down to my last skin, expose me as a mother. Was I a fool for having expectations, for assuming that medicine or prayer or time would be enough? Read More: Kids Can’t Get COVID-19 ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 nationpod Source Type: news

Related Links:

Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
AbstractPurposeThe trial aimed to investigate the effectiveness of exogenous melatonin as an adjuvant to pregabalin for relief of pain in patients suffering from painful diabetic neuropathy (PDN).Patients and methodsThis randomized, double-blind, placebo-controlled trial was carried out between October 2019 and December 2020 in an outpatient specialty clinic in Iran. One-hundred-three type 2 diabetic patients suffering from PDN were randomized into either the melatonin group (n  = 52) or the placebo group (n = 51). Besides pregabalin at a dose of 150 mg per day, patients started with melato...
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
According to the American Cancer Society, about 1 in 5 cancers in the US and about 1 in 6 cancer deaths can be linked to poor nutrition, being overweight, not exercising, or alcohol.WebMD Health News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
This study aimed to understand the extent to which cannabis-related risk perception and COVID-19-related health worries were associated with the reported reduction in sharing cannabis smoking products to mitigate the risk of the coronavirus transmission or infection. This association was tested in two different periods in terms of toughness of national lockdown policy imposed in the first months of the pandemic in Israel. The study population included adult recreational cannabis users who completed one of the two online cross-sectional surveys dedicated to COVID-19 and the cannabis use situation in Israel in the first h...
Source: Drugs and Alcohol Today - Category: Addiction Authors: Source Type: research
“Last March, I was working in a small primary care practice on the west side of Denver. COVID-19 came to town. On Thursday, March 12, we were told the schools would be closing. On Friday, we were told that clinic staff had to wear masks — and the clinic had to start testing patients forRead more …I was thinking about retiring, and COVID-19 gave me a push [PODCAST] originally appeared
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Podcast COVID-19 coronavirus Infectious Disease Primary Care Source Type: blogs
OHSU's vaccination results are in line with other major Portland health systems.
Source: Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
The FDA has followed the advice of its advisory panels, approving additional doses of Moderna and J&J vaccines, and opening up people's options by letting them switch vaccine type for their booster.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news
Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
Source: Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
The U.S. Food and Drug Administration has given the O.K. to Covid-19 vaccine "booster" shots made by Cambridge biotech Moderna Inc. Moderna (Nasdaq: MRNA) is now able to make and distribute boosters — third shots identical to each of the first two in the series, but half the amount — for patients 65 and older, adults with underlying medical conditions and adults who are at a high risk for Covid-19 because of their occupati ons or time in institutional settings. The decision comes a few days…
Source: Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
More News: Academies | Brain | Burns | Child Development | Children | Contracts | COVID-19 | Emergency Medicine | Genetics | Health | Health Management | Hospitals | Neurology | Nightmares | Nurses | Nursing | Nutrition | Outbreaks | Pandemics | Pediatrics | Politics | Science | Skin | Sleep Disorders | Sleep Medicine | Study | Sugar | Vaccines